vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and FARMERS NATIONAL BANC CORP (FMNB). Click either name above to swap in a different company.
FARMERS NATIONAL BANC CORP is the larger business by last-quarter revenue ($71.5M vs $44.9M, roughly 1.6× AbCellera Biologics Inc.). FARMERS NATIONAL BANC CORP runs the higher net margin — 20.5% vs -19.9%, a 40.4% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 3.2%). FARMERS NATIONAL BANC CORP produced more free cash flow last quarter ($52.2M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 6.2%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Farmers National Banc Corp (OH) is a regional financial holding company based in Ohio, the United States. It offers full-spectrum retail and commercial banking products, wealth management solutions, and insurance services, primarily catering to individual consumers, small and medium-sized enterprises, and local community clients in Ohio and adjacent Midwestern U.S. regions.
ABCL vs FMNB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $71.5M |
| Net Profit | $-8.9M | $14.6M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 24.8% |
| Net Margin | -19.9% | 20.5% |
| Revenue YoY | 788.4% | 3.2% |
| Net Profit YoY | 73.9% | 1.7% |
| EPS (diluted) | $-0.03 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $71.5M | ||
| Q3 25 | $9.0M | $70.8M | ||
| Q2 25 | $17.1M | $69.8M | ||
| Q1 25 | $4.2M | $67.8M | ||
| Q4 24 | $5.0M | $69.3M | ||
| Q3 24 | $6.5M | $70.3M | ||
| Q2 24 | $7.3M | $66.5M | ||
| Q1 24 | $10.0M | $63.4M |
| Q4 25 | $-8.9M | $14.6M | ||
| Q3 25 | $-57.1M | $12.5M | ||
| Q2 25 | $-34.7M | $13.9M | ||
| Q1 25 | $-45.6M | $13.6M | ||
| Q4 24 | — | $14.4M | ||
| Q3 24 | $-51.1M | $8.5M | ||
| Q2 24 | $-36.9M | $11.8M | ||
| Q1 24 | $-40.6M | $11.2M |
| Q4 25 | -63.7% | 24.8% | ||
| Q3 25 | -851.8% | 20.7% | ||
| Q2 25 | -290.2% | 23.4% | ||
| Q1 25 | -1479.6% | 24.1% | ||
| Q4 24 | — | 25.5% | ||
| Q3 24 | -1439.4% | 14.4% | ||
| Q2 24 | -1276.2% | 21.3% | ||
| Q1 24 | -551.5% | 21.2% |
| Q4 25 | -19.9% | 20.5% | ||
| Q3 25 | -637.8% | 17.6% | ||
| Q2 25 | -203.3% | 19.9% | ||
| Q1 25 | -1077.2% | 20.0% | ||
| Q4 24 | — | 20.8% | ||
| Q3 24 | -785.4% | 12.1% | ||
| Q2 24 | -504.3% | 17.7% | ||
| Q1 24 | -408.0% | 17.7% |
| Q4 25 | $-0.03 | $0.39 | ||
| Q3 25 | $-0.19 | $0.33 | ||
| Q2 25 | $-0.12 | $0.37 | ||
| Q1 25 | $-0.15 | $0.36 | ||
| Q4 24 | — | $0.38 | ||
| Q3 24 | $-0.17 | $0.23 | ||
| Q2 24 | $-0.13 | $0.31 | ||
| Q1 24 | $-0.14 | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | — |
| Total DebtLower is stronger | — | $86.7M |
| Stockholders' EquityBook value | $966.9M | $485.7M |
| Total Assets | $1.4B | $5.2B |
| Debt / EquityLower = less leverage | — | 0.18× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | — | ||
| Q2 25 | $92.4M | — | ||
| Q1 25 | $159.3M | — | ||
| Q4 24 | $156.3M | — | ||
| Q3 24 | $126.6M | — | ||
| Q2 24 | $148.3M | — | ||
| Q1 24 | $123.6M | — |
| Q4 25 | — | $86.7M | ||
| Q3 25 | — | $86.6M | ||
| Q2 25 | — | $86.4M | ||
| Q1 25 | — | $86.3M | ||
| Q4 24 | — | $86.2M | ||
| Q3 24 | — | $86.0M | ||
| Q2 24 | — | $88.9M | ||
| Q1 24 | — | $88.8M |
| Q4 25 | $966.9M | $485.7M | ||
| Q3 25 | $964.0M | $465.9M | ||
| Q2 25 | $1.0B | $437.7M | ||
| Q1 25 | $1.0B | $429.1M | ||
| Q4 24 | $1.1B | $406.0M | ||
| Q3 24 | $1.1B | $439.7M | ||
| Q2 24 | $1.1B | $396.7M | ||
| Q1 24 | $1.1B | $397.0M |
| Q4 25 | $1.4B | $5.2B | ||
| Q3 25 | $1.4B | $5.2B | ||
| Q2 25 | $1.4B | $5.2B | ||
| Q1 25 | $1.3B | $5.2B | ||
| Q4 24 | $1.4B | $5.1B | ||
| Q3 24 | $1.4B | $5.2B | ||
| Q2 24 | $1.4B | $5.2B | ||
| Q1 24 | $1.5B | $5.1B |
| Q4 25 | — | 0.18× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.20× | ||
| Q1 25 | — | 0.20× | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.22× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $60.0M |
| Free Cash FlowOCF − Capex | $-44.6M | $52.2M |
| FCF MarginFCF / Revenue | -99.4% | 73.0% |
| Capex IntensityCapex / Revenue | 21.9% | 11.0% |
| Cash ConversionOCF / Net Profit | — | 4.10× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $85.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $60.0M | ||
| Q3 25 | $-52.6M | $10.7M | ||
| Q2 25 | $-32.4M | $14.0M | ||
| Q1 25 | $-11.6M | $15.7M | ||
| Q4 24 | $-108.6M | $66.6M | ||
| Q3 24 | $-28.9M | $23.9M | ||
| Q2 24 | $-30.0M | $16.6M | ||
| Q1 24 | $-41.7M | $13.7M |
| Q4 25 | $-44.6M | $52.2M | ||
| Q3 25 | $-61.5M | $9.0M | ||
| Q2 25 | $-45.8M | $12.4M | ||
| Q1 25 | $-22.2M | $12.2M | ||
| Q4 24 | $-187.0M | $54.9M | ||
| Q3 24 | $-47.4M | $20.4M | ||
| Q2 24 | $-50.1M | $14.4M | ||
| Q1 24 | $-65.8M | $12.2M |
| Q4 25 | -99.4% | 73.0% | ||
| Q3 25 | -687.0% | 12.8% | ||
| Q2 25 | -267.9% | 17.8% | ||
| Q1 25 | -524.0% | 18.0% | ||
| Q4 24 | -3702.8% | 79.2% | ||
| Q3 24 | -728.4% | 29.1% | ||
| Q2 24 | -683.8% | 21.6% | ||
| Q1 24 | -661.5% | 19.2% |
| Q4 25 | 21.9% | 11.0% | ||
| Q3 25 | 99.7% | 2.4% | ||
| Q2 25 | 78.2% | 2.3% | ||
| Q1 25 | 251.1% | 5.2% | ||
| Q4 24 | 1552.7% | 16.9% | ||
| Q3 24 | 284.6% | 4.9% | ||
| Q2 24 | 274.6% | 3.3% | ||
| Q1 24 | 242.5% | 2.4% |
| Q4 25 | — | 4.10× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 1.01× | ||
| Q1 25 | — | 1.15× | ||
| Q4 24 | — | 4.63× | ||
| Q3 24 | — | 2.80× | ||
| Q2 24 | — | 1.41× | ||
| Q1 24 | — | 1.22× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
